http://www.nektar.com
Nektar Therapeutics Company Intro
Nektar's new pathways to smarter medicine bring hope to millions of patients by creating innovative medicines that treat serious & widespread unmet medical needs.
Industry
Healthcare
Nektar Therapeutics Headquaters
455 Mission Bay Boulevard South
San Francisco,94158
United States
Nektar Therapeutics Share price
20 Oct 2020 02:10 GMT
$17.16
0.02 (0.12 %)
Nektar Therapeutics Market cap
$3.018 B
WMC RANKING
2020
Nektar Therapeutics # 38
BiotechnologyLatest Nektar Therapeutics News
20 Oct 2020
Opioid Induced Constipation (OIC) Drugs Market Set for Rapid ...
... Pfizer, Progenics Pharmaceuticals Inc, Shionogi & Co., Ltd, Allergan Plc, Nektar Therapeutics, Purdue Pharma, S.L.A. Pharma AG, Mundipharma International ...
20 Oct 2020
Global NK Cell Therapy Market 2020 Industry Statistics ...
... Nektar Therapeutics, Kiadis Pharma, Chipscreen Biosciences, Innate Pharma ... Nkarta Therapeutics, Glycostem Therapeutics, Fate Therapeutics, NantWorks, ...
20 Oct 2020
Polymers Drug Delivery: Market with Coronavirus Impact Analysis | Industry Business Outlook, Revenue, Trends and Forecasts 2025 | Sanofi, Johnson & Johnson, Inovio Pharmaceuticals, Alkermes, Janssen Biotech, Heron
Sanofi Johnson & Johnson Inovio Pharmaceuticals Alkermes Janssen Biotech Heron Eisai Perrigo Quark Pharmaceuticals Inc ... Nektar Therapeutics Allergan
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Nektar Therapeutics | 2.93 | 1.76 | 0.49 | 0 | 0 | 0 | 1.85 |
| Alexion Pharmaceuticals, Inc. | 100 | 11.92 | 100 | 19 | 0 | 0 | 98.18 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.66 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.03 |
| Incyte Corporation | 40.27 | 14.19 | 7.07 | 100 | 0 | 0 | 91.05 |
Nektar Therapeutics Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Nektar Therapeutics | $162,500 | $516,529 | $-429,400 | $3.018B | 38 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.687B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $57.436B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.572B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.193B | 4 |